Enlightify (ENFY) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for November 2025 in Xi'an, China, to review company activities, financial performance, and elect directors.

• Key proposals include director elections, amendment to the 2023 Equity Incentive Plan, approval of a significant stock issuance, and a reverse stock split.

• Shareholders of record as of September 2025 are eligible to vote; quorum is one-third of outstanding shares.

Voting matters and shareholder proposals

• Election of seven directors to serve until the next annual meeting.

• Approval to amend the 2023 Equity Incentive Plan, increasing authorized shares by 3 million.

• Approval for issuance of over 20% of outstanding common stock via a public offering with warrants.

• Authorization for a reverse stock split at a ratio between 1-for-5 and 1-for-20 within 24 months.

• Other business matters may be considered if properly brought before the meeting.

Board of directors and corporate governance

• Board consists of seven members, with four qualifying as independent under NYSE rules.

• Board committees: Audit, Compensation, and Nominating, all composed of independent directors.

• Board held eight meetings and approved eight written consents in fiscal 2024; all directors attended at least 75% of meetings.

• Lead independent director structure in place to enhance oversight.

• Code of Ethics and Corporate Governance Guidelines adopted and available on the company website.